Vaccine hesitancy was rising even before COVID-19 emerged – but the pandemic exacerbated the trend. More kindergartners are ...

BioNTech began working on a vaccine ... dose, they were already planning the Phase 3 trials to evaluate whether the vaccines were effective and safe. [What you need to know about the Moderna ...

The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies ...

HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...

(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.

The review is part of a government push to examine spending on messenger RNA-based vaccines, the technology that powered Moderna’s Covid vaccine. The bird flu shot contract was awarded to ...

Adam Glanzman / Bloomberg via Getty Images Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE ...

The Moderna JN.1 vaccine for adults is a single-dose prefilled 0.5ml syringe, and the children’s is 0.25ml, she said. Following the depletion of vaccines for children, the Advisory Committee on ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.

“The reality is that it’s been studied,” said Richard Hughes IV, a former vice president of public policy at vaccine maker Moderna who teaches vaccine law at the George Washington University ...

New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an important strategy for providing immunity as quickly as possible during a ...